Epstein-Barr virus: the mastermind of immune chaos

被引：16
作者：
Silva, Jean de Melo [1 ,2 ]
Alves, Carlos Eduardo de Castro [1 ]
Pontes, Gemilson Soares [1 ,2 ]
机构：
[1] Natl Inst Amazonian Res INPA, Lab Virol & Immunol, Manaus, AM, Brazil
[2] Univ Fed Amazonas, Inst Biol Sci, Postgrad Program Basic & Appl Immunol, Manaus, AM, Brazil
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词：
EBV; herpesvirus; evasion; innate immunity; acquired immunity; NF-KAPPA-B; NATURAL-KILLER-CELLS; CLASS-II EXPRESSION; MEMBRANE-PROTEIN; GENE-EXPRESSION; DENDRITIC CELLS; NLRP3; INFLAMMASOME; BHRF1; PROTEIN; T-BET; EBV;
D O I：
10.3389/fimmu.2024.1297994
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The Epstein-Barr virus (EBV) is a ubiquitous human pathogen linked to various diseases, including infectious mononucleosis and multiple types of cancer. To control and eliminate EBV, the host's immune system deploys its most potent defenses, including pattern recognition receptors, Natural Killer cells, CD8+ and CD4+ T cells, among others. The interaction between EBV and the human immune system is complex and multifaceted. EBV employs a variety of strategies to evade detection and elimination by both the innate and adaptive immune systems. This demonstrates EBV's mastery of navigating the complexities of the immunological landscape. Further investigation into these complex mechanisms is imperative to advance the development of enhanced therapeutic approaches with heightened efficacy. This review provides a comprehensive overview of various mechanisms known to date, employed by the EBV to elude the immune response, while establishing enduring latent infections or instigate its lytic replication.
引用
收藏
页数：16
相关论文
共 188 条
  • [41] EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
    Fang, Wenfeng
    Zhang, Jianwei
    Hong, Shaodong
    Zhan, Jianhua
    Chen, Nan
    Qin, Tao
    Tang, Yanna
    Zhang, Yaxiong
    Kang, Shiyang
    Zhou, Ting
    Wu, Xuan
    Liang, Wenhua
    Hu, Zhihuang
    Ma, Yuxiang
    Zhao, Yuanyuan
    Tian, Ying
    Yang, Yunpeng
    Xue, Cong
    Yan, Yue
    Hou, Xue
    Huang, Peiyu
    Huang, Yan
    Zhao, Hongyun
    Zhang, Li
    [J]. ONCOTARGET, 2014, 5 (23) : 12189 - 12202
  • [42] EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9
    Fathallah, Ikbal
    Parroche, Peggy
    Gruffat, Henri
    Zannetti, Claudia
    Johansson, Hanna
    Yue, Jiping
    Manet, Evelyn
    Tommasino, Massimo
    Sylla, Bakary S.
    Hasan, Uzma A.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (11) : 6439 - 6447
  • [43] EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins
    Fitzsimmons, Leah
    Cartlidge, Rachel
    Chang, Catherine
    Sejic, Nenad
    Galbraith, Laura C. A.
    Suraweera, Chathura D.
    Croom-Carter, Deborah
    Dewson, Grant
    Tierney, Rosemary J.
    Bell, Andrew, I
    Shannon-Lowe, Clare
    Herold, Marco J.
    Rickinson, Alan B.
    Colman, Peter M.
    Huang, David C. S.
    Strasser, Andreas
    Kvansakul, Marc
    Rowe, Martin
    Kelly, Gemma L.
    [J]. CELL DEATH AND DIFFERENTIATION, 2020, 27 (05) : 1554 - 1568
  • [44] The role of microRNAs in Epstein-Barr virus latency and lytic reactivation
    Forte, Eleonora
    Luftig, Micah A.
    [J]. MICROBES AND INFECTION, 2011, 13 (14-15) : 1156 - 1167
  • [45] The Epstein-Barr Virus EBNA1 Protein
    Frappier, Lori
    [J]. SCIENTIFICA, 2012, 2012
  • [46] Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections
    Gaglia, Marta Maria
    [J]. VIROLOGY JOURNAL, 2021, 18 (01)
  • [47] AN EBNA-1-DEPENDENT ENHANCER ACTS FROM A DISTANCE OF 10-KILOBASE PAIRS TO INCREASE EXPRESSION OF THE EPSTEIN-BARR-VIRUS LMP GENE
    GAHN, TA
    SUGDEN, B
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2633 - 2636
  • [48] Galperin C, 1994, Rev Hist Sci Paris, V47, P7, DOI 10.3406/rhs.1994.1189
  • [49] EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation
    Gilardini Montani, Maria Saveria
    Santarelli, R.
    Granato, M.
    Gonnella, R.
    Torrisi, M. R.
    Faggioni, A.
    Cirone, M.
    [J]. AUTOPHAGY, 2019, 15 (04) : 652 - 667
  • [50] The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
    Gram, Anna M.
    Oosenbrug, Timo
    Lindenbergh, Marthe F. S.
    Bull, Christian
    Comvalius, Anouskha
    Dickson, Kathryn J. I.
    Wiegant, Joop
    Vrolijk, Hans
    Lebbink, Robert Jan
    Wolterbeek, Ron
    Adema, Gosse J.
    Griffioen, Marieke
    Heemskerk, Mirjam H. M.
    Tscharke, David C.
    Hutt-Fletcher, Lindsey M.
    Wiertz, Emmanuel J. H. J.
    Hoeben, Rob C.
    Ressing, Maaike E.
    [J]. PLOS PATHOGENS, 2016, 12 (04)
12345678910